Randomized controlled trial of early arachidonic acid and docosahexaenoic acid enteral supplementation in very preterm infants

HIGHLIGHTS

• who: Miguel Saenz de Pipaon from the George Emil Palade University Center, United States have published the Article: Randomized controlled trial of early arachidonic acid and docosahexaenoic acid enteral supplementation in very preterm infants, in the Journal: (JOURNAL)
• what: The aim was to assess in very preterm infants the blood changes of LCPUFAs and oxylipin levels from birth to 36 WPA after providing an emulsified ARA:DHA supplement. The authors aimed to evaluate the effects of the intervention on neonatal morbidities and brain size and function at 36 WPA.
• how: The following cUS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.